LIVE LONGER. LIVE BETTER.

2024 Year in Review

2024 was transformative for Relavo Medical, marked by strategic growth, groundbreaking achievements, and impactful recognition.

Here’s a look back at our major milestones:

FUNDING MILESTONE

We opened our Series A funding round, led by Keiretsu Forum Mid-Atlantic. This funding provides us with the critical resources to enhance our innovative solutions and expand our presence in the healthcare market.

TECHNOLOGY & INNOVATION

Our technology achieved a major milestone with the publication of our US patent. This accomplishment reinforces our position as a leader in healthcare innovation, safeguarding the unique aspects of our solution and paving the way for scaling its impact.

LEADERSHIP EXPANSION

We proudly welcomed Pete Schommer to our Board of Directors. Pete brings over 25 years of experience in the medical device industry, including senior leadership roles at Kendall Healthcare, Covidien, and Medtronic. As Founder and CEO of Surgenti Consulting LLC, Pete’s expertise in launching innovative products and revitalizing business lines will be instrumental in driving Relavo’s growth and innovation.

GRANT AWARD

Relavo was awarded a $500,000 NSF SBIR Phase IIB grant, a pivotal achievement in our journey. This funding advances the development of our PeritoneX System, a novel connection device designed to reduce infection risks in peritoneal dialysis by internally disinfecting dialysis tubes with antimicrobial solutions.

THOUGHT LEADERSHIP

Our CEO, Sarah Lee, delivered the keynote address at the American Kidney Fund (AKF) Patient Access Initiative Summit. Sarah’s leadership at this impactful event highlighted Relavo’s commitment to addressing healthcare access challenges and improving early diagnosis and intervention for kidney disease patients.

As we look ahead, we remain steadfast in our mission to revolutionize healthcare and improve patient outcomes for those with PD. Thank you to our partners, stakeholders, and team for making this year a success.